Arcturus Therapeutics
ARCT
ARCT
38 hedge funds and large institutions have $46.6M invested in Arcturus Therapeutics in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
23% less capital invested
Capital invested by funds: $60.3M → $46.6M (-$13.6M)
53% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 15
Holders
38
Holding in Top 10
2
Calls
$52.5M
Puts
$39.1M
Top Buyers
| 1 | +$3.71M | |
| 2 | +$2.01M | |
| 3 | +$1.35M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$649K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$543K |
Top Sellers
| 1 | -$5.76M | |
| 2 | -$3.33M | |
| 3 | -$2.42M | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$2.27M |
| 5 |
SC
Sophrosyne Capital
New York
|
-$2.22M |